Terragen is pleased to share that its previously announced Charles Sturt University feedlot trial has now been accepted for publication and is live in the Journal of Translational Animal Science. While this is not a new trial announcement, it is an important milestone: the results have now entered the peer-reviewed literature, giving producers, advisers and investors an additional level of confidence in how the findings can be assessed.Why this mattersIn agricultural biologicals, proof matters.Producers do not need more noise. They need confidence that a product has been tested properly, that results have been scrutinised externally, and that performance is being communicated with precision. That is what publication adds here.The CSU paper is based on the previously announced feedlot trial in 264 purebred Angus steers over 106 days on feed. It compared a control ration with no probiotic against liquid and dried direct-fed microbial treatments at different dose rates.What the published [...]

Terragen Holdings Limited (ASX: TGH) is pleased to share the final independent report from Laconik, a technology enabler for on-farm trials for growers and agribusiness, assessing the performance of Great Land Plus® (GLP) in a commercial silage maize system. The replicated commercial-scale assessment demonstrated a 12% increase in yield following application of GLP at 4 L/ha under the conditions of the trial Key Highlights GLP outperformed all other treatments, including GLP combined with kelp 12% increase in silage yield at 4 L/ha Estimated additional gross revenue of approximately $1,100 per hectare above standard practice Potential grower ROI of up to 20 times at a treatment cost of $55/ha inclusive of GLP and application Results supported by 13 replicated data sets conducted at commercial scale Independent, Replicated and Commercial The assessment was independently conducted by Laconik and included 13 replicated data sets across four different product applications in a commercial grower environment in the [...]